<DOC>
	<DOC>NCT00121628</DOC>
	<brief_summary>The purpose of the study is to determine if AMG 706 will have clinically meaningful anti-tumor activity in subjects with locally advanced or metastatic thyroid cancer who are not candidates for radioactive iodine therapy or local therapies.</brief_summary>
	<brief_title>A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Histologically confirmed locally advanced or metastatic thyroid cancer Measurable disease Normal blood pressure (if history of hypertension, blood pressure must be controlled with medication) Evidence of disease progression within 6 months before starting study (for differentiated thyroid cancer subjects) Evidence of disease progression within 6 months before starting study OR symptomatic disease (for medullary thyroid cancer subjects) Not a candidate for surgical resection, external beam radiotherapy, radioiodine therapy, or other local therapy At least 18 years of age Undifferentiated/anaplastic thyroid cancer Untreated or symptomatic brain metastases Prior malignancy, unless cured with treatment and no evidence of disease for greater than or equal to 3 years before starting study (history of thyroid cancer, in situ cervical cancer, or basal cell cancer of skin are exceptions) Myocardial infarction or any unstable cardiac condition (e.g., congestive heart failure, unstable angina) within 1 year before starting study Arterial thrombosis or deep vein thrombosis within 1 year before starting study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Thyroid cancer</keyword>
	<keyword>Advanced thyroid cancer</keyword>
	<keyword>Metastatic thyroid cancer</keyword>
	<keyword>Medullary thyroid cancer</keyword>
	<keyword>Follicular thyroid cancer</keyword>
	<keyword>Papillary thyroid cancer</keyword>
	<keyword>Hurthle cell thyroid cancer</keyword>
	<keyword>Thyroid cancer treatments</keyword>
	<keyword>Differentiated thyroid cancer and medullary thyroid cancer</keyword>
</DOC>